21 C.F.R. § 601.44
Postmarketing safety reporting.
Cite as 21 C.F.R. § 601.44 (2026)
Biological products approved under this program are subject to the postmarketing recordkeeping and safety reporting applicable to all approved biological products.
21 C.F.R. § 601.44
Cite as 21 C.F.R. § 601.44 (2026)